As Hahn reasserts FDA’s independence . . .

Giroir Tries To Ease Concerns About New HHS Rulemaking Policy

By Beth Wang / September 23, 2020 at 5:01 PM
HHS Assistant Secretary for Health Brett Giroir tried to assure senators Wednesday (Sept. 23) that HHS’ decision to require all health agency rules to be formally signed by HHS Secretary Alex Azar will not interrupt agencies’ rulemaking processes. Sen. Susan Collins (R-ME), however, said it seems inevitable the new requirement will cause some delays and will spur new doubts about the Trump administration’s pandemic response. Collins’ concerns about the new rulemaking procedure, which puts Azar, a political appointee, in charge...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.